1. Home
  2. AES vs TXG Comparison

AES vs TXG Comparison

Compare AES & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The AES Corporation

AES

The AES Corporation

SELL

Current Price

$14.93

Market Cap

10.6B

Sector

Utilities

ML Signal

SELL

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

SELL

Current Price

$56.11

Market Cap

9.3B

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
AES
TXG
Founded
1981
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Laboratory Analytical Instruments
Sector
Utilities
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.6B
9.3B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
AES
TXG
Price
$14.93
$56.11
Analyst Decision
Hold
Buy
Analyst Count
9
17
Target Price
$15.00
★ $68.14
AVG Volume (30 Days)
★ 8.1M
3.0M
Earning Date
11-03-2026
11-05-2026
Dividend Yield
★ 4.72%
N/A
EPS Growth
N/A
★ 76.97
EPS
★ 2.04
N/A
Revenue
★ $12,233,000,000.00
$245,893,000.00
Revenue This Year
$7.93
N/A
Revenue Next Year
$1.78
$11.72
P/E Ratio
$7.31
★ N/A
Revenue Growth
N/A
★ 68.06
52 Week Low
$13.28
$15.18
52 Week High
$17.65
$102.81

Technical Indicators

Market Signals
Indicator
AES
TXG
Relative Strength Index (RSI) 51.13 37.75
Support Level $14.83 $18.13
Resistance Level $15.03 $63.82
Average True Range (ATR) 0.05 6.09
MACD -0.00 -1.09
Stochastic Oscillator 45.45 9.45

Price Performance

Historical Comparison
AES
TXG

About AES The AES Corporation

AES is a global power company that operates in 15 countries. Its generation portfolio totals over 32 gigawatts, including renewable energy (50%), gas (32%), coal (16%), and oil (2%). AES owns a majority stake and operates six electric utilities, distributing power to more than 2.5 million customers.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Share on Social Networks: